EP Multibagger Stock - March 2026
gift nifty image banner
Want a perfect stocks portfolio for 2026? Create Now
Latest News

German regulator rejects GMP approval to DRL’s Bachupally Unit2

The German regulator has not renewed good manufacturing practise (GMP) compliance certificate of Dr Reddy’s Laboratories formulations facility 2 in Bachupally in Hyderabad.

Dr Reddy’s Laboratories said in a BSE filing that the communication came after a recent inspection of the plant.

It added that Betapharm Arzneimittel GmbH, Germany, the company’s wholly owned arm received a communication “from the regulatory authority of Germany (Regiergun von Oberbayern) last night, that the GMP compliance certificate in respect of company’s formulations manufacturing Unit 2 plant in Bachupally, Hyderabad, is not renewed consequent to the recent inspection of the plant.”

Read EquityPandit’s Technical Analysis on Nifty Pharma

Click here to check market prediction for next trading session.

Get Daily Prediction & Stocks Advise On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.



Is this the right time to invest?